Clinical trials: Cardiac Transplantion
Kidney Transplant; Complications
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
EFFEKTOR is a vanguard, multicenter, phase 2 randomized, double blinded, placebo controlled clinical trial to determine the feasibility, tolerability, safety, and efficacy of finerenone in kidney transplant recipients (KTRs).
- Trial name
- NCT06059664
- Testing
- Finerenone Oral Tablet
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of North Carolina, Chapel Hill
Cardiac Transplantion
LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant
Primary Objective: Evaluation of the benefit on renal function of one year of a low dose of ciclosporine versus the usual dose Secondary Objective: To evaluate the immunosuppressive efficacy and tolerance of the treatment Study…
- Trial name
- NCT00159159
- Testing
- Ciclosporine 130 µg/l < T0 ciclosporinemia < 200 µg/l, Ciclosporine 200 µg/l < T0 ciclosporinemia < 300 µg/l
- Where
- France
- Volunteers
- 106 people
- Sponsor
- Hospices Civils de Lyon